|1.||Rewers, Marian J: 1 article (07/2011)|
|2.||Barker, Jennifer M: 1 article (07/2011)|
|3.||Triolo, Taylor M: 1 article (07/2011)|
|4.||Gottlieb, Peter A: 1 article (07/2011)|
|5.||Eisenbarth, George S: 1 article (07/2011)|
|6.||Baker, Peter R: 1 article (07/2011)|
|7.||Fain, Pam R: 1 article (07/2011)|
|8.||Armstrong, Taylor K: 1 article (07/2011)|
|9.||Siebert, Janet C: 1 article (07/2011)|
|10.||Nanduri, Priyaanka: 1 article (07/2011)|
|1.||Coronary Disease (Coronary Heart Disease)
|2.||Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/01/1986 - "Haplotype studies showed that the extended haplotype [HLA-B15, C2-1, C4-A3B3, Bf-S, HLA-DR4] had a particularly strong association to IDDM. "
01/01/1986 - "The frequency of the extended haplotype [HLA-B15, C2-1, C4-A3B3, Bf-S, HLA-DR4] was increased also among the parents to the IDDM probands compared to those of the control parents, whereas the frequency of [HLA-B7, C2-1, C4-A3B1, Bf-S, HLA-DR2] was decreased. "
01/01/1987 - "The prevalence of tissue type HLA-B15 has been shown to be higher in atopic patients with benign migratory glossitis and in patients with insulin-dependent diabetes mellitus than it is in the general population. "
12/01/1982 - "There was an increased frequency of HLA-B15 in all categories of patients: those with onset before 40 yr, those with onset after 40 yr (P less than 0.05), those with IDDM (P less than 0.05), and those with non-insulin-dependent diabetes mellitus (NIDDM). "
01/01/1985 - "The results of the present work showed that patients with IDDM showed a significant increase in frequency of HLA-A2, HLA-B8 and HLA-B15. "
07/07/1984 - "These results confirm those of a previous study carried out in the same unit, which showed a 41% incidence of HLA B15 antigen in patients with chondrocalcinosis. "
07/07/1984 - "Calculation of the relative risk shows that an elderly subject with HLA B15 antigen if about 4 times more liable to articular chondrocalcinosis than a subject without this antigen."
04/01/1983 - "Seven of 16 patients (44%) with EM and 5 of 9 patients (55%) with EM following herpes simplex infections possessed the HLA-B15 antigen, compared to 7% of local controls and 11.6% of the 1980 WHO Workshop Caucasian controls. "
01/01/1996 - "The association of HLA-B15 antigen and HbsAg supports the idea of some genetic control of HBV infection in the patients with HCC."
01/01/1991 - "The HLA-DR2 representation is responsible for a high specific process risk and HLA-A11 and HLA-B15 can be characterized as antigens causing a resistance to tuberculosis infection."
|9.||Terminator Codon (Termination Codon)
|10.||HLA-DR4 Antigen (HLA DR4 Antigen)
|1.||Bone Marrow Transplantation (Transplantation, Bone Marrow)